The TPP, IP and the Australasian healthcare industry - what's at stake?

there are fears that the TPP may reduce access to affordable medicines throughout the region party to the agreement. Additionally, many worry that the TPP may not be flexible enough to accommodate existing non-discriminatory drug reimbursement programs and the diverse health systems of the member countries. Full Story »

Posted by Dwight Rousu
Tags Help
Editorial Help
Posted by: Posted by Dwight Rousu - Jan 27, 2013 - 8:47 PM PST
Content Type: Article
Edit Lock: This story can be edited
Edited by: Dwight Rousu - Jan 27, 2013 - 8:50 PM PST

Reviews

Show All | Notes | Comments | Quotes | Links
Dwight Rousu
4.0
by Dwight Rousu - Jan. 27, 2013
See Full Review » (10 answers)
charles Ibe
by charles Ibe - Jan. 30, 2013

Yes it is a good journalism because of how they summarised the austrlian helath care which is actually different from American helth care. However there is a fundamental differences in which the scope and operation is enforced and established. This explains that they are draft clauses and schemes which relates to affordable wide range of settings.

See Full Review » (1 answer)

Comments on this story Help (BETA)

NT Rating | My Rating

Ratings

4.0

not enough reviews
from 2 reviews (12% confidence)
Quality
3.9
Facts
4.0
Fairness
4.0
Sourcing
3.0
Style
3.0
Context
4.0
Depth
4.0
Enterprise
5.0
Relevance
4.0
Popularity
4.3
Recommendation
5.0
Credibility
4.0
# Reviews
1.0
# Views
5.0
# Likes
1.0
# Emails
1.0
More
How our ratings work »
(See these related stories.)

Links Help

No links yet. Please review this story to add some!